© 1999 American Heart Association, Inc.
Original Contribution |
Endothelial Implants Inhibit Intimal Hyperplasia After Porcine Angioplasty
From the Harvard-MIT Division of Health Sciences and Technology (H.M.N, C.R., E.R.E), Massachusetts Institute of Technology, Cambridge, Mass; Cardiovascular Division (C.R., E.R.E), Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, Boston, Mass.
Correspondence to Helen M. Nugent, PhD, Harvard-MIT Division of Health Sciences and Technology, MIT, 16-343, Cambridge, MA 02139. E-mail nugent{at}mit.edu
Abstract—The perivascular implantation of tissue-engineered endothelial cells around injured arteries offers an opportunity to study fundamental vascular physiology as well as restore and improve tissue function. Cell source is an important issue because the ability to implant either xenogeneic or allogeneic cells would greatly enhance the clinical applications of tissue-engineered grafts. We investigated the biological and immunological responses to endothelial cell xenografts and allografts in pigs 4 weeks after angioplasty of the carotid arteries. Porcine or bovine aortic endothelial cells were cultured within Gelfoam matrices and implanted in the perivascular space of 42 injured arteries. Both porcine and bovine endothelial cell grafts reduced the restenosis index compared with control by 54% and 46%, respectively. Perivascular heparin release devices, formulated to release heparin at twice the rate of release of heparan sulfate proteoglycan from endothelial cell implants, produced no significant reduction in the restenosis index. Endothelial cell implants also reduced occlusive thrombosis compared with control and heparin release devices. Host immune responses to endothelial implants were investigated by immunohistochemical examination of explanted devices and by immunocytochemistry of serum samples. The bovine cell grafts displayed infiltration of leukocytes, consisting primarily of lymphocytes, and caused an increase in antibodies detected in serum samples. Reduced cellular infiltration and no humoral response were detected in animals that received allografts. Despite the difference in immune response, the biological effects of xenografts or allografts did not differ significantly.
Key Words: tissue engineering • restenosis • perivascular • heparin • thrombosis
This article has been cited by other articles:
 |
|
 |
|
  R. Gulati and R. D. Simari Defining the potential for cell therapy for vascular disease using animal models Dis. Model. Mech., March 1, 2009; 2(3-4): 130 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. G. Zani, K. Kojima, C. A. Vacanti, and E. R. Edelman Tissue-engineered endothelial and epithelial implants differentially and synergistically regulate airway repair PNAS, May 13, 2008; 105(19): 7046 - 7051. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Methe, A. Groothuis, M. H. Sayegh, and E. R. Edelman Matrix adherence of endothelial cells attenuates immune reactivity: induction of hyporesponsiveness in allo- and xenogeneic models FASEB J, May 1, 2007; 21(7): 1515 - 1526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. V. Pislaru, A. Harbuzariu, R. Gulati, T. Witt, N. P. Sandhu, R. D. Simari, and G. S. Sandhu Magnetically Targeted Endothelial Cell Localization in Stented Vessels J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1839 - 1845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Roy-Chaudhury, V. P. Sukhatme, and A. K. Cheung Hemodialysis Vascular Access Dysfunction: A Cellular and Molecular Viewpoint J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1112 - 1127. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Methe, H. M. Nugent, A. Groothuis, P. Seifert, M. H. Sayegh, and E. R. Edelman Matrix Embedding Alters the Immune Response Against Endothelial Cells In Vitro and In Vivo Circulation, August 30, 2005; 112(9_suppl): I-89 - I-95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Schwartz, N. A. Chronos, and R. Virmani Preclinical restenosis models and drug-eluting stents: Still important, still much to learn J. Am. Coll. Cardiol., October 6, 2004; 44(7): 1373 - 1385. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. G. Melo, M. Gnecchi, A. S. Pachori, D. Kong, K. Wang, X. Liu, R. E. Pratt, and V. J. Dzau Endothelium-Targeted Gene and Cell-Based Therapies for Cardiovascular Disease Arterioscler Thromb Vasc Biol, October 1, 2004; 24(10): 1761 - 1774. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L.G Melo, M Gnecchi, A.S Pachori, K Wang, and V.J Dzau Gene- and cell-based therapies for cardiovascular diseases: current status and future directions Eur. Heart J. Suppl., September 1, 2004; 6(suppl_E): E24 - E35. [Abstract] [Full Text]
|
|
|
|
|
|
D. L. Myers, K. J. Harmon, V. Lindner, and L. Liaw Alterations of Arterial Physiology in Osteopontin-Null Mice Arterioscler Thromb Vasc Biol, June 1, 2003; 23(6): 1021 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Nugent and E. R. Edelman Tissue Engineering Therapy for Cardiovascular Disease Circ. Res., May 30, 2003; 92(10): 1068 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D MacNeill, I. Pomerantseva, H. C Lowe, S. N Oesterle, and J. P Vacanti Toward a new blood vessel Vascular Medicine, August 1, 2002; 7(3): 241 - 246. [Abstract] [PDF]
|
|
|
|
|
|
A. Bayes-Genis, R. S. Schwartz, D. A. Lewis, M. T. Overgaard, M. Christiansen, C. Oxvig, K. Ashai, D. R. Holmes Jr, and C. A. Conover Insulin-Like Growth Factor Binding Protein-4 Protease Produced by Smooth Muscle Cells Increases in the Coronary Artery After Angioplasty Arterioscler Thromb Vasc Biol, March 1, 2001; 21(3): 335 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Nugent, H. M. Nugent, R. V. Iozzo, K. Sanchack, and E. R. Edelman Perlecan is required to inhibit thrombosis after deep vascular injury and contributes to endothelial cell-mediated inhibition of intimal hyperplasia PNAS, June 6, 2000; 97(12): 6722 - 6727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S Ettenson and E. R Edelman Local drug delivery: an emerging approach in the treatment of restenosis Vascular Medicine, May 1, 2000; 5(2): 97 - 102. [Abstract] [PDF]
|
|
|
|
|
|
E. R. Edelman Vascular Tissue Engineering : Designer Arteries Circ. Res., December 3, 1999; 85(12): 1115 - 1117. [Full Text] [PDF]
|
|